Is 1P-LSD legal in New Zealand?
- Legal status
- 1P-LSD is treated in New Zealand as a controlled drug analogue of lysergide (LSD, a Class A controlled drug) under the Misuse of Drugs Act 1975: a substance with a structure substantially similar to a controlled drug is itself a Class C controlled drug.
- Consequences if caught
- As a Class C controlled drug analogue, supplying or manufacturing 1P-LSD carries up to 8 years' imprisonment, and possession up to 3 months and/or a NZ$500 fine (a custodial term is generally unavailable for a first Class C possession).
- If prescribed or medical
- No approved medicinal or prescription use; controlled-drug analogues have no recognised therapeutic listing.
- Documentation
- Confirmed via the Misuse of Drugs Act 1975 controlled-drug-analogue definition; lysergide/LSD is Class A and structurally-similar lysergamides such as 1P-LSD default to Class C.
Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with New Zealand’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately — not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →